AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 141 min read$ANIX

Titterton Lewis H jr purchased $27K of ANIX

Titterton Lewis H jr purchased 10,000 shares of Anixa Biosciences Inc (ANIX) at $2.73 on 2026-09-10.

Original reporting
SEC EDGAR · Titterton Lewis H jr
Published Sep 14, 2026, 1:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 1:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ANIX
Neutral
medium confidence
Mentioned
$ANIX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ANIXNeutralLow
01

Why it matters

The transaction is too small to affect market perception materially.

02

Market read

Limited relevance; likely no immediate trading action.

03

What to watch

Potential upcoming clinical data or partnership not disclosed.

Relevance 4/10Novelty 4/10Timing: filed today

Background

Form 4 filings disclose insider transactions; this is a routine purchase by a director.

Company-level read

Ticker impact

$ANIXNeutralMedium confidence
Context

Director Titterton Lewis H Jr purchased 10,000 shares of Anixa Biosciences for $27,300, disclosed via Form 4.

Expected impact

little to no immediate price effect

Evidence & confidence

Purchase amount is small relative to total holdings and market cap; unlikely to move price.

Market effects

Sector

None significant for biotech sector.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

Insider purchase could be a subtle bullish signal despite small size.

Key entities

  • Company
    Anixa Biosciences Inc

    Biotech firm listed on NASDAQ under ticker ANIX.

  • Person
    Titterton Lewis H Jr

    Director of Anixa Biosciences.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ANIX insider trading history →

Related articles

SEP 11
$ANIXMedAI 8/10

RedChip Companies, Inc.: Anixa Biosciences and Nexalin Technology Interviews to Air Nationally on the RedChip Small Stocks, Big Money Show on CNBC and Bloomberg TV

RedChip Companies will air interviews with Anixa Biosciences (NASDAQ:ANIX) and Nexalin Technology (NASDAQ:NXL) on Bloomberg TV and CNBC. Anixa is developing a breast cancer vaccine, while Nexalin focuses on neurostimulation for mental health. Both companies are preparing for key trials and commercialization efforts.

finanznachrichten.de2 min
SEP 17
$XBPLow

Avenue RP Opportunities Fund, L.P. (LASRY MARC) purchased $1.5M of XBP (indirect holdings)

Avenue RP Opportunities Fund, L.P. purchased 527,606 indirectly-held shares of XBP Global Holdings, Inc. (XBP) at $2.83 ($1.49M total) across 2 trades on 2026-09-15. Filed jointly with Avenue Global Dislocation Opportunities Fund, L.P. (10% owner), Avenue Europe International Management, L.P. (10% owner), Avenue Capital Management II, L.P. (10% owner), Avenue RP Opportunities Fund GenPar, LLC (10% owner), Avenue Global Dislocation Opportunities GenPar, LLC (10% owner), GL RP Partners, LLC (10% owner), GL Global Dislocation Opportunities Partners, LLC (10% owner) and LASRY MARC (10% owner).

SEC EDGAR1 min